RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • … , placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact …

… , placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact …

Add to Collection
RCTs SM Jain, R Balamurugan, M Tandon, N Mozaffarian… - Pain, 2022 - ncbi.nlm.nih.gov

Chapter : Section1
Journal Year : 2022
Cited by : 14.0

… 11-point pain intensity numeric rating scale. The study did not … 75 years (18-65 years in India) diagnosed with DM (type 1 or 2… of the condition, and laboratory changes that were reported …..... Read More

Keywords : ["painful diabetic peripheral neuropathy impact", "transient receptor potential ankyrin", "placebocontrolle trial", "oral inhibitor", "patient", "isc"]
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100440/
Google Scholar Link : https://scholar.google.com/scholar?cites=9532461146410657654&as_sdt=5,39&sciodt=0,39&hl=en&num=20